Pharmafile Logo

TechnologyAdvice

- PMLiVE

Merck and Lilly enter Keytruda collaboration

Will research anti-PD-1 cancer therapy as part of combination treatment

- PMLiVE

Medical device M&A hit ‘all-time high’ in 2014

Deals last year were led by Medtronic’s acquisition of Covidien

- PMLiVE

emotive expands its team

Anjani Patel, Adam Goodband and Lucy Allen take up new roles

- PMLiVE

Communicating in a crisis

GCI Health’s Wendy Lund argues that health situations like the Ebola outbreak need to be treated on the same level as a natural disaster

- PMLiVE

McCann Complete Medical expands into new Glasgow offices

Moves Complete Medical Communications and Complete HealthVizion employees to Skypark

- PMLiVE

AZ’s Brilinta clears cardiovascular outcomes trial

Found to reduce chance of recurring cardiovascular events

Bristol Myers Squibb logo

BMS and Lilly to jointly research Opdivo combination

PD-1 inhibitor will be tested with Lilly's galunisertib

Daiichi Sankyo logo

Daiichi Sankyo pays $39m in whistleblower case

Accused of paying US doctors to prescribe its drugs

- PMLiVE

Cuttsy and Cuttsy appoints Jill Bradshaw

She joins as an account director from VCCP Health

- PMLiVE

New UCB CEO Jean-Christophe Tellier expands his executive team

Hands new roles to Emmanuel Caeymaex, Bharat Tewarie and Jeff Wren

- PMLiVE

Pharma condemns Cancer Drugs Fund cuts

NHS England says 16 medicines across 25 indications will be removed from list

- PMLiVE

NICE says cost of Dendreon’s cancer vaccine is too high

Another blow as the bankrupt company goes to auction next month

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links